BTIG
John Newman, Ph.D.
212-389-8042
Canaccord Genuity
Kristen Kluska
212-915-1927
Cantor Fitzgerald & Co.
Mitchell S. Kapoor
212-356-0513
H.C. Wainwright & Co.
Leerink Partners
Uy Ear
212-209-9445
Mizuho Securities USA, LLC
Gil Blum, Ph.D.
212-705-0383
Needham & Company
William Blair

Selecta Biosciences, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Selecta's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Selecta or its management. Selecta does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.